Wilson Sonsini Advises Circle Pharma on $90 Million Series D

Wilson Sonsini Advises Circle Pharma On $90 Million Series D

1 week from now

Sep 12, 2024  · Client Highlights. September 12, 2024. On September 3, 2024, Circle Pharma, a clinical-stage biopharmaceutical company dedicated to discovering and developing cell …

wsgr.com

Insights | Wilson Sonsini

1 week from now

Wilson Sonsini Advises Circle Pharma on $90 Million Series D. On September 3, 2024, Circle Pharma, a clinical-stage biopharmaceutical company dedicated to discovering and developing …

wsgr.com

Circle Pharma Closes $90 Million Series D Financing To Advance ...

1 week from now

Sep 3, 2024  · SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Circle Pharma, a clinical-stage biopharmaceutical company dedicated to discovering and developing cell-permeable …

circlepharma.com

Circle Pharma Closes $90 Million Series D Financing To Advance ...

1 week from now

Sep 3, 2024  · Roslyn Patterson 650.825.4099 [email protected]. SOUTH SAN FRANCISCO, Calif., September 03, 2024--Circle Pharma, a clinical-stage biopharmaceutical …

yahoo.com

Circle Pharma Closes $90 Million Series D Financing To Advance ...

1 week from now

Sep 3, 2024  · Circle Pharma Closes $90 Million Series D Financing to Advance Innovative Oral Macrocycle Therapies. Circle Pharma, a clinical-stage biopharmaceutical company dedicated …

morningstar.com

Circle Pharma’s $90 Million Series D Financing Round – Global …

1 week from now

Sep 20, 2024  · Circle Pharma’s $90 Million Series D Financing Round. September 20, 2024 Leila Ahmed. Tagged: 9-20-2024 Circle Pharma Davelyn Couch Elton Satusky Jesse Schumaker …

globallegalchronicle.com

Insights | Wilson Sonsini

1 week from now

Wilson Sonsini Advises Circle Pharma on $90 Million Series D. On September 3, 2024, Circle Pharma, a clinical-stage biopharmaceutical company dedicated to discovering and developing …

wsgr.com

Wilson Sonsini Goodrich & Rosati’s Post - LinkedIn

1 week from now

Congratulations on the $90 million Series D, Circle Pharma, Inc.! Learn more about the transaction and Wilson Sonsini team, led by Elton Satusky and Jesse…

linkedin.com

Circle Pharma Raises $90M Series D Round - Vcnewsdaily.com

1 week from now

Sep 3, 2024  · Circle Pharma, a clinical-stage biopharmaceutical company dedicated to discovering and developing cell-permeable macrocycles as a new class of therapies, today …

vcnewsdaily.com

Circle Pharma Closes $90 Million Series D Financing To Advance ...

1 week from now

Sep 3, 2024  · SOUTH SAN FRANCISCO, Calif.– Circle Pharma, a clinical-stage biopharmaceutical company dedicated to discovering and developing cell-permeable …

blstimes.com

Circle Pharma Closes $90 Million Series D Financing To Advance …

1 week from now

Sep 9, 2024  · Key Highlights. Circle Pharma raises $90 million in Series D funding led by The Column Group. Funding to support clinical trials of CID-078 and expand the company’s …

sliceofhealthcare.com

Series D - Circle Pharma - 2024-09-03 - Crunchbase

1 week from now

Sep 3, 2024  · Circle Pharma. Announced Date Sep 3, 2024. Closed On Date Sep 3, 2024. Funding Type Series D. Funding Stage Late Stage Venture. Money Raised. $90M.

crunchbase.com

Bill Barrett On LinkedIn: Wilson Sonsini Advises Circle Pharma On …

1 week from now

A Wilson Sonsini team led by Elton Satusky and Jesse Schumaker advised Circle Pharma on their $90 million Series D! ... Wilson Sonsini Advises Strider on $55 Million Series C

linkedin.com

Elton Satusky | Wilson Sonsini - Wilson Sonsini Goodrich & Rosati

1 week from now

Wilson Sonsini Advises Circle Pharma on $90 Million Series D. On September 3, 2024, Circle Pharma, a clinical-stage biopharmaceutical company dedicated to discovering and developing …

wsgr.com

Circle Pharma Closes $90 Million Series D Financing To Advance ...

1 week from now

Share This Article. SOUTH SAN FRANCISCO, Calif., September 3, 2024-- Circle Pharma, a clinical-stage biopharmaceutical company dedicated to discovering and developing cell …

vcaonline.com

Emily T Campbell On LinkedIn: Wilson Sonsini Advises Circle …

1 week from now

A Wilson Sonsini team led by Elton Satusky and Jesse Schumaker advised Circle Pharma on their $90 million Series D! Wilson Sonsini Advises Circle Pharma on $90 Million Series D …

linkedin.com

John Cohn On LinkedIn: Wilson Sonsini Advises Circle Pharma On …

1 week from now

A Wilson Sonsini team led by Matt Squires, Robert Terenzi, and Luis Roberto Fortuño recently advised Strider Technologies, a leading provider of strategic intelligence, on their $55 million …

linkedin.com

Circle Pharma Closes $90 Million Series D Financing To Advance ...

1 week from now

Sep 3, 2024  · Circle Pharma, a clinical-stage biopharmaceutical company dedicated to discovering and developing cell-permeable macrocycles as a new class of therapies, today …

wedbush.com

Wilson Sonsini Advises Circle Pharma On Research …

1 week from now

Oct 9, 2024  · Wilson Sonsini advised Circle on the transaction. The collaboration will expand Boehringer Ingelheim’s oncology portfolio and support its target to transform cancer care. In connection with the agreement, Circle will receive an upfront payment and potential development, regulatory, and sales milestone payments worth up to $607 million.

wsgr.com